Citadel Advisors’s Lux Health Tech Acquisition Corp. Units LUXAU Stock Holding History

Citadel Advisors’s Portfolio LUXAU Stock Details LUXAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,076	Closed	-$101K	–	14728
2022 Q1	$101K	Sell	10,076 -647	-6%	-$6.45K	﹤0.01%	12280
2021 Q4	$108K	Sell	10,723 -144	-1%	-$1.47K	﹤0.01%	12647
2021 Q3	$110K	Buy	+10,867	New	+$111K	﹤0.01%	12763
2021 Q2	–	Sell	-15,708	Closed	-$167K	–	14760
2021 Q1	$167K	Buy	+15,708	New	+$186K	﹤0.01%	11933

Other funds holding LUXAU

BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

SFM

Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return

Citadel Advisors's LUXAU Position: Q2 2022 in Review

Citadel Advisors sold out of Lux Health Tech Acquisition Corp. Units (LUXAU) in Q2 2022, closing a stake of 10,076 shares — an estimated $101K sold.

Citadel Advisors first reported a position in LUXAU in Q1 2021 and held it in 4 quarters. The position peaked at $167K in Q1 2021. 14 funds tracked by Wall St. Rank hold LUXAU as of Q2 2022.

Citadel Advisors reported no remaining Lux Health Tech Acquisition Corp. Units position as of Q2 2022 after selling out during the quarter.
Citadel Advisors sold 10,076 Lux Health Tech Acquisition Corp. Units shares in Q2 2022, an estimated $101K.
Citadel Advisors first reported a position in Lux Health Tech Acquisition Corp. Units in Q1 2021 and held it in 4 quarters.
Citadel Advisors's Lux Health Tech Acquisition Corp. Units position peaked at $167K in Q1 2021.
14 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Units as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.